| Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo S Attalla, T Taifour, T Bui, W Muller Oncogene 40 (3), 475-491, 2021 | 120 | 2021 |
| Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression I Nandi, HW Smith, V Sanguin-Gendreau, L Ji, A Pacis, V Papavasiliou, ... The Journal of Clinical Investigation 133 (7), 2023 | 9 | 2023 |
| The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer T Taifour, SS Attalla, D Zuo, Y Gu, V Sanguin-Gendreau, H Proud, ... Immunity 56 (12), 2755-2772. e8, 2023 | 8 | 2023 |
| Tailoring therapies to counter the divergent immune landscapes of breast cancer S Attalla, T Taifour, W Muller Frontiers in Cell and Developmental Biology 11, 1111796, 2023 | 5 | 2023 |
| HER2Δ16 engages ENPP1 to promote an immune-cold microenvironment in breast cancer SS Attalla, J Boucher, H Proud, T Taifour, D Zuo, V Sanguin-Gendreau, ... Cancer immunology research 11 (9), 1184-1202, 2023 | 2 | 2023 |
| Abstract PO2-25-01: Tumor Derived Chitinase-3 like 1 Induces Neutrophil Extracellular Traps that Promote T cell Exclusion and Resistance to Immunotherapies in Breast Cancer T Taifour, SS Attalla, D Zuo, Y Gu, V Sanguin-Gendreau, H Dall-Proud, ... Cancer Research 84 (9_Supplement), PO2-25-01-PO2-25-01, 2024 | | 2024 |
| Mechanisms of tumor immune modulation and stemness in breast cancer S Attalla McGill University, 2024 | | 2024 |
William J. MullerProfessor, McGill UniversityVerified email at mcgill.ca
